Zegocractin (development code CM-4620) is a drug which acts as a selective inhibitor of the calcium channel ORAI1. It inhibits store-operated calcium entry (SOCE) and has anti-inflammatory effects.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.